|Year : 2012 | Volume
| Issue : 1 | Page : 44-49
Moringa oleifera Lam.: Protease activity against blood coagulation cascade
A Satish, Sudha Sairam, Faiyaz Ahmed, Asna Urooj
Department of Studies in Food Science and Nutrition, University of Mysore, Mysore, Karnataka, India
|Date of Submission||01-Jul-2011|
|Date of Decision||04-Sep-2011|
|Date of Web Publication||21-Dec-2011|
Department of Studies in Food Science and Nutrition, University of Mysore, Mysore - 570 006, Karnataka
Source of Support: University Grant Commission in the Special Assistance Program, New Delhi, India (NO.F.640/1/DRS/2007(SAP-I), Conflict of Interest: None
| Abstract|| |
Background : The present study evaluated the protease activity of aqueous extracts of Moringa oleifera (Moringaceae) leaf (MOL) and root (MOR). Materials and Methods : Protease activity was assayed using casein, human plasma clot and human fibrinogen as substrates. Results : Caseinolytic activity of MOL was significantly higher (P ≤ 0.05) than that of MOR. Similar observations were found in case of human plasma clot hydrolyzing activity, wherein MOL caused significantly higher (P ≤ 0.05) plasma clot hydrolysis than MOR. Zymographic techniques were used to detect proteolytic enzymes following electrophoretic separation in gels. Further, both the extracts exhibited significant procoagulant activity as reflected by a significant decrease (P ≤ 0.05) in recalcification time, accompanied by fibrinogenolytic and fibrinolytic activities; clotting time was decreased from 180 ± 10 sec to 119 ± 8 sec and 143 ± 10 sec by MOL and MOR, respectively, at a concentration of 2.5 mg/mL. Fibrinogenolytic (human fibrinogen) and fibrinolytic activity (human plasma clot) was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), plate method and colorimetric method. Zymographic profile indicated that both the extracts exerted their procoagulant activity by selectively hydrolyzing Aa and Bb subunits of fibrinogen to form fibrin clot, thereby exhibiting fibrinogenolytic activity. However, prolonged incubation resulted in degradation of the formed fibrin clot, suggesting fibrinolytic like activity. Conclusions : These findings support the traditional usage of M. oleifera extracts for wound healing.
Keywords: Caseinolytic, fibrinogenolytic, fibrinolytic, Moringa oleifera, procoagulant
|How to cite this article:|
Satish A, Sairam S, Ahmed F, Urooj A. Moringa oleifera Lam.: Protease activity against blood coagulation cascade. Phcog Res 2012;4:44-9
|How to cite this URL:|
Satish A, Sairam S, Ahmed F, Urooj A. Moringa oleifera Lam.: Protease activity against blood coagulation cascade. Phcog Res [serial online] 2012 [cited 2021 May 11];4:44-9. Available from: http://www.phcogres.com/text.asp?2012/4/1/44/91034
| Introduction|| |
It is well known that proteases hydrolyze peptide bonds of proteins and they differ in their substrate specificity and ability to hydrolyze various peptide bonds. Proteases are involved in a multitude of physiological reactions from simple digestion of food proteins to highly regulated reactions such as blood cascade, complement system, and apoptosis pathways.  Several plant latex proteases are known to interfere in hemostasis as procoagulants, suggesting their unique substrate preference over other proteases. , Cysteine proteases from the Asclepiadaceae plants latex were reported to exhibit thrombin and plasmin like activities.  Proteases interfering in blood coagulation and fibrin hydrolysis have been isolated and characterized from several plant latexes. Ficin, a cysteine protease from Ficus carica, and a serine protease from Synadenium grantii were shown to involve in blood coagulation and fibrin hydrolysis. ,
Coagulation is a complex process by which blood forms clots. It is an important part of hemostasis (the cessation of blood loss from a damaged vessel), wherein a damaged blood vessel wall is covered by a platelet and fibrin-containing clot to stop bleeding and begin repair of the damaged vessel. Disorders of coagulation can lead to an increased risk of bleeding (hemorrhage) or clotting (thrombosis). In patients with advanced liver disease, bleeding and thrombosis are dangerous complications, particularly in those who are challenged by infection or who require surgery. 
Moringa oleifera is a tree of the Moringaceae family, widely cultivated throughout the tropics and subtropics, and its leaves, seed pods, seeds, seed oil, roots, bark, flowers, and sap are commonly consumed as food and used in traditional medicines. Its use as an inexpensive component in foods, nutritional supplements, or medicines by patients with HIV/AIDS has been advocated by several African governments.  It possesses anti-inflammatory, antioxidant, antimicrobial, antifertility, anticancer, antihepatotoxic and antiulcer activities. 
Reports have shown that the products of traditionally used plants such as Bryophyllum pinnatum and M. oleifera promoted healing in experimental animals. , The M. oleifera roots and seeds are prescribed for the treatment of snake bites and scorpion stings.  M. oleifera leaves are also reported to have hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in rats.  These plants contain a mixture of several hydrolytic enzymes, in which proteases are the key enzymes responsible for the observed pharmacological actions. Hence, the aim of the present study was to investigate the protease activity of aqueous extracts of M. oleifera leaf and root against the blood coagulation cascade.
| Materials and Methods|| |
Human fibrinogen and thrombin were purchased from Sigma Aldrich, Bangalore, India. Casein was purchased from Sisco Research Laboratory, Mumbai, India. Fresh human blood samples were collected from healthy volunteers. All other chemicals and reagents used in the study were of analytical grade.
Collection of the sample and preparation of the extracts
The root and the leaves of M. oleifera were collected from Mysore district during November 2009, identified by Dr. Shivprasad Hudeda, and a voucher specimen was retained in the laboratory for future reference. The samples were thoroughly cleaned, dried in hot air oven at 37°C overnight, powdered, passed through 60 mesh sieve and stored at 4°C until further use. The root was cleaned, cut into small pieces, dried in the oven at 37°C overnight, powdered, passed through 60 mesh sieve and stored at 4°C until further use. Aqueous extracts were prepared by extracting the powdered samples (50 g) with distilled water (1:8 w/v) in a mechanical shaker for 24 h at room temperature. The extracts were then filtered and freeze dried.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed according to the method of Laemmli.  Polyacrylamide gel electrophoresis (PAGE 7.5%) under neutral conditions was carried out for aqueous extracts of leaf (MOL) and root (MOR).
Caseinolytic activity was assayed using denatured casein as substrate.  Briefly, 0.4 mL casein (2%) in 0.2 M Tris-HCl buffer, pH 8.5, was incubated separately with different concentrations of MOL and MOR in a final volume of 1 mL for 2 h at 37°C. The reaction was stopped by adding 1.5 mL of 0.44 M trichloroacetic acid (TCA) and the mixture was allowed to stand for 30 min. The reaction mixture was centrifuged at 1500 g for 15 min. An aliquot (1 mL) of the supernatant was mixed with 2.5 mL of 0.4 M sodium carbonate and 0.5 mL of Folin reagent (1:2, v/v). The color developed was read at 660 nm. Activity was expressed as units/h. One unit of enzyme activity was defined as the amount of enzyme required to increase the absorbance by 0.01 at 660 nm/h.
Casein-zymography was performed according to the method of Kim et al, with SDS-PAGE 7.5% containing 0.1% (w/v) casein. MOL and MOR (1-3 mg) were incubated with SDS-PAGE sample buffer without 2-mercaptoethanol for 30 min at 37°C and the samples were subjected to SDS-PAGE. After electrophoresis, the gels were washed in 2.5% (v/v) Triton X-100 in Tris buffer, pH 7.5, for 15 min twice and then incubated in the incubation buffer at 37°C for 12-24 h under shaking, and stained with Coomassie Brilliant Blue R and then destained. The area of digestion appears as clear bands against a darkly stained background where the substrate has been degraded by the enzyme.
Coagulant activity was determined according to the procedure described by Condrea et al, Fresh human blood was mixed with 0.11 M trisodium citrate (1:9, v/v). The mixture was centrifuged for 15 min at 1500 g0 and the supernatant obtained was platelet poor plasma (PPP). To 300 μL of PPP, 30 μL of 0.01 M Tris-HCl buffer (pH 7.4) was added and pre-warmed to 37°C, following which 1 mg of sample was added and incubated for 1 min. The clot formation was initiated by adding 30 μL of 0.25 M CaCl2 . The time taken for the formation of visible clot from the time of addition of CaCl 2 was recorded. Control experiment was carried without the addition of sample.
Fibrinogen hydrolyzing activity was estimated according to the method of Ouyang and Teng.  Human fibrinogen (50 μg) in 10 mM Tris-HCl buffer, pH 7.4, was incubated with 1 mg MOL and MOR in a reaction volume of 40 μL for 30 min at 37°C. The reaction was terminated by adding 20 μL of sample buffer containing 4% -mercaptoethanol, 1 M urea and 4% SDS, and subjected to SDS-PAGE (10%). The fibrinogen-hydrolyzing pattern was visualized by staining with Coomassie Brilliant Blue R-250.
Fibrinogen polymerization assay
Fibrinogen polymerization assay was carried out by slightly modifying the method of Joo et al, Three milliliters of 1.2% agarose warmed to 50°C was mixed with 3 mL of 0.4% (w/v) fibrinogen dissolved in 0.1 M Tris-HCl (pH 7.4). Fibrinogen-agarose mixture was poured into a Petri plate and allowed to solidify for 1 h at room temperature. Wells of about 3 mm diameter were made on the plate, and 20 μL of buffer containing 1 mg of MOL and MOR was introduced into the well and incubated at 37°C for 2 h. The zone of fibrin rings formed due to the polymerization of fibrinogen was observed. 0.2 unit of thrombin was used as positive control and the buffer alone served as control.
SDS-PAGE analysis of plasma clot hydrolysis
The assay was carried out as described by Rajesh et al, Briefly, the washed plasma clot (cross-linked fibrin) was incubated with different amounts of MOL and MOR extracts (1-3 mg) separately in a reaction volume of 40 μL containing 10 mM Tris-HCl buffer, pH 7.4, for 12 h. The reaction was terminated by adding 20 μL of sample buffer containing 4% β-mercaptoethanol and 1 M urea, boiled for 3 min and centrifuged to settle the debris of plasma clot. An aliquot (20 μL) of the supernatant was subjected to 7.5% SDS-PAGE to analyze fibrin hydrolyzing pattern.
Plasma clot hydrolyzing activity
Plasma hydrolyzing activity was assayed according to the method by Rajesh et al, Briefly, 100 μL of citrated human plasma was mixed with 30 μL of 0.25 M CaCl2 and incubated for 2 h at 37°C. The clot obtained was washed thoroughly for 5-6 times with phosphate buffered saline (PBS) and suspended in 400 μL of 0.2 M Tris-HCl buffer, pH 8.5. The reaction was initiated by adding varying amounts of MOL and MOR (1-5 mg) in 100 μL of 10 mM Tris-HCl buffer, pH 7.4, and incubating for 2 h 30 min at 37°C. The undigested clot was precipitated by adding 750 μL of 0.44 M TCA and allowed to stand for 30 min and centrifuged for 15 min at 1500 g. The aliquots of 0.5 mL supernatant were transferred to clean glass tubes, followed by the addition of 1.25 mL of 0.4 M sodium carbonate and 0.25 mL of 1:3 diluted Folin and Ciocalteu's phenol (FC) reagent. The color developed was read at 660 nm after allowing the tubes to stand for 30 min. One unit of activity is defined as the amount of enzyme required to increase the absorbance by 0.01 at 660 nm/h (37°C).
Plasma clot hydrolyzing activity (fibrinolytic activity)
The method described by Gene et al, was followed with slight modification.  A mixture consisting of 2 mL of healthy human plasma and 3 mL of 1.2% molten agarose (45°C) in 10 mM Tris-HCl buffer containing 0.02% sodium azide, 70 mM (NH4) 2 SO 4 , 90 mM NaCl, 0.70 mM MgCl2 and 200 μL of 0.2 M CaCl2 was poured into 10 × 90 mm Petri dish More Details and allowed to stand for 2 h at 27°C. Different concentrations of MOL and MOR (1-2 mg) were placed separately on the surface of the gel matrix and incubated for 12 h at 27°C. The diameters of the clear zones (plaque) were noted. 10 μL of 10 mM Tris-HCl buffer, pH 7.4, served as control.
Measurements made were mean of triplicate determinations, and wherever applicable, the data were analyzed by analysis of variance (ANOVA) followed by Tukey's multiple comparisons test for significant difference using SPSS 16.0 software.
| Results and Discussion|| |
The present study showed the protease activity of aqueous extracts of M. oleifera leaf and root in blood coagulation cascade. Presence of proteolytic activity is one of the important characteristic features of the plant. These crude extracts were subjected to electrophoresis under SDS-PAGE (7.5%) in a non-reducing condition. In both the extracts, clearly distinguishable protein bands were resolved in gel [Figure 1].
|Figure 1: SDS-PAGE of MOL and MOR. 1 mg concentration of each of the samples was loaded onto the 7.5% SDS-PAGE and electrophoresis was performed in a constant current under non-reducing condition using Tris-glycine buffer. (a) MOL and (b) MOR|
Click here to view
The extracts were assessed for proteolytic activity using denatured casein as substrate. Both the extracts showed proteolytic activity in a dose-dependent manner. The leaf extract was found to exhibit significantly higher (P ≤ 0.05) activity compared to the root extract [Figure 2]. For further detecting the protease activity, we used the casein-zymographic technique [Figure 3]. This action is due to the presence of proteolytic enzymes and evoked further investigation on its effect on pure fibrinogen. Both the extracts hydrolyze the Aα and Bβ chains of fibrinogen subunits, but not γ chain. Hydrolyzing pattern of fibrinogen was monitored using 10% SDS-PAGE under reduced conditions, along with thrombin-induced fibrin clot [Figure 4]. Thrombin like enzymes hydrolyze Aα and Bβ chains of fibrinogen at the N-terminal disulfide knot and from fibrin by releasing fibrinopeptide.  Further, the fibrinogenolytic like activity of MOL and MOR was compared with known units of thrombin enzyme, using fibrinogen agar plate. [Figure 5] shows the polymerization of fibrinogen by both the extracts. At the concentration of 1 mg, the diameter of the zone of fibrin rings formed due to the polymerization of fibrinogen was similar to the zone area produced by 0.2 unit of thrombin, suggesting that both the extracts have fibrinogenolytic activity. The proteolytic activity that hydrolyzes fibrinogen can either induce clot or prolong clot formation. The clot inducing or prolonging ability of these extracts was studied by determining the recalcification time of human citrated plasma. The extracts promoted clot formation after addition of CaCl 2 to human citrated plasma. The induction of clot was from 180 ± 10 sec to 119 ± 8 sec in MOL, while MOR decreased the clotting time to 143 ± 10 sec at a concentration of 2.5 mg/mL. Hydrolysis of fibrinogen by both the extracts results in the formation of fibrin clot (fibrinogenolytic activity). This study very clearly suggested that both MOL and MOR extracts exhibited procoagulant activity after addition of CaCl 2 to human citrated plasma, and reduced the recalcification time in clot formation by activating the factors or by precipitating the co-factors involved in the blood coagulation cascade. The observed procoagulant activity/fibrinogenolytic activity might be the basis for the use of extracts to stop bleeding by traditional healers.
|Figure 2: Caseinolytic activity of MOL and MOR extracts. One unit of enzyme activity was defined as the amount of enzyme required to increase the absorbance by 0.01 at 660 nm/h. Caseinolytic activity of MOL (- -) and MOR (- -) extracts. One milliliter of reaction mixture contained 0.4 mL of casein 2% in 0.2 M Tris-HCl buffer, pH 8.5, incubated with different concentrations of extracts ranging from 1 to 5 mg for 2 h at 37°C|
Click here to view
|Figure 3: Protease activity of MOL and MOR by zymography method. Includes casein as a substrate copolymerized with the polyacrylamide gel, for the detection of enzyme activity. Substrate degradation products were resolved in 7.5% SDS-PAGE. Lane A, MOR (1 mg); Lane B, MOR (2 mg); Lane C, MOR (3 mg); Lane D, MOL (1 mg); Lane E, MOL (2 mg); Lane F, MOL (3 mg)|
Click here to view
|Figure 4: Electrophoresis pattern of fibrinogen by extracts. Reaction mixture of volume 40 μL contained 50 μg fibrinogen incubated with 1 mg of MOL and MOR in 10 mM Tris-Hcl buffer, pH 7.4, at 37°C for 30 min. Hydrolyzing pattern of fibrinogen was monitored by 10% SDS-PAGE under reduced condition. (A) 50 μg fibrinogen, (B) 50 μg fibrinogen + 0.2 units thrombin, (C) 50 μg fibrinogen + 1 mg MOL and (D) 50 μg fibrinogen + 1 mg MOR|
Click here to view
|Figure 5: Fibrinogen-agarose plate assay to determine thrombin like activity of MOL and MOR. (A) Buffer alone, (B) buffer + thrombin (0.2 units), (C) buffer + 1 mg MOL, (D) buffer + 1 mg MOR|
Click here to view
Besides fibrinogenolytic activity, the extracts exhibited plasma clot hydrolyzing properties on prolonged incubation, resulting in degradation of the formed fibrin clot, which suggests fibrinolytic like activity by the hydrolysis of only few subunits of α-polymer, α-chains, β-chains of crude fibrin clot in a dose-dependent manner. To substantiate these clot hydrolyzing properties, the hydrolyzed products of fibrin clots were analyzed on SDS-PAGE 7.5% [Figure 6] under reducing condition, colorimetric method and plate method [Figure 7] and [Figure 8]. Eventually, blood clots are reorganized and resorbed by a process termed fibrinolysis. The main enzyme responsible for this process (plasmin) is regulated by various activators and inhibitors. Plasmin is generated by proteolytic cleavage of plasminogen, a plasma protein synthesized in the liver. This cleavage is catalyzed by tissue plasminogen activator (t-PA), which is synthesized and secreted by endothelium. Plasmin proteolytically cleaves fibrin into fibrin degradation products that inhibit excessive fibrin formation and hemostatic plug, facilitating wound healing.  However, extracts of leaf (MOL) and root (MOR) exhibited a mixture of both fibrinogenolytic and fibrinolytic activities. Present data suggested the dual action of crude extracts, i.e. both fibrinogenolytic and fibrinolytic activities, might be due to the presence of thrombin and plasmin like enzymes or a single enzyme responsible for the dual action.
|Figure 6: Dose-dependent hydrolysis of plasma clot by MOL and MOR. The washed plasma clot was incubated separately with the different concentrations of extract for 12 h in 40 μL of 10 mM Tris-HCl buffer, pH 7.4, at 37°C. The samples included (A) plasma clot alone, (B) plasma clot treated with MOL 1 mg, (C) plasma clot with MOL 2 mg, (D) plasma clot treated with MOL 3 mg, (E) plasma clot treated with MOR l mg, (F) plasma clot treated with MOR 2 mg and (G) plasma clot treated with MOR 3 mg|
Click here to view
|Figure 7: Concentration-dependent hydrolysis of human plasma clot. One unit of enzyme activity was defined as the amount of enzyme required to increase the absorbance by 0.01 at 660 nm/h|
Click here to view
|Figure 8: Fibrinolytic activity of MOL and MOR. The samples in 10 μL of 10 mM Tris-HCl buffer, pH 7.4, were separately placed on the surface of the gel and incubated for 12 h at 27°C. (A) Buffer alone, (B) MOL 1 mg, (C) MOL 2 mg, (D) MOR 1 mg, (E) MOR 2 mg|
Click here to view
| Conclusion|| |
The study provides scientific validation for the use of M. oleifera in traditional medicine as an anticoagulant. The results suggest the involvement/presence of thrombin and plasmin like enzymes. Further studies are needed to understand the mechanism of action. Hence, attempts are underway to purify both thrombin and plasmin like proteases from M. oleifera leaf and root to promote their pharmacological utilization.
| Acknowledgment|| |
The authors acknowledge the funding assistance received from University Grant Commission in the Special Assistance Program, New Delhi, India (NO.F.640/1/DRS/2007(SAP-I).
| References|| |
|1.||Konno K, Hirayama C, Masatoshi N, Tateishi K, Tamura Y, Hattori M, et al0. Papain protects papaya trees from herbivorous insects: Role of cysteine proteases in latex. Plant J 2004;37:370-8. |
|2.||Rajesh R, Shivaprasad HV, Gowda RC, Nataraju A, Dhananjaya BL, Vishwanath BS. Comparative study on plant latex proteases and their involvement in hemostasis: A special emphasis on clot inducing and dissolving properties. Planta Med 2007;73:1061-7. |
|3.||Richter G, Hans PS, Friedrich D, Peter L. Activation and inactivation of human factor X by proteases derived from Ficus carica. Br J Haematol 2002;119:1042-51. |
|4.||Shivaprasad HV, Riyaz M, Kumar VR, Dharmappa KK, Tarannum S, Siddesha JM. Cysteine proteases from the Asclepiadaceae plants latex exhibited thrombin and plasmin like activities. J Thromb Thrombolysis 2008;28:304-8. |
|5.||Rajesh R, Gowda CD, Nataraju A, Dhananjaya BL. Purification and characterization of a 34-kDa, heat stable glycoprotein from Synadenium grantii latex: Action on human fibrinogen and fibrin clot. Biochimie 2006;88:1313-22. |
|6.||Mehta AB. Management of coagulopathy in patients with liver disease undergoing surgical intervention. Indian J Gastroenterol 2006;25:19-21. |
|7.||Anwar F, Latif S, Ashraf M, Gilani AH. Moringa oleifera: A food plant with multiple medicinal uses. Phytother Res 2007;21:1725. |
|8.||Goyal BR, Agrawal BB, Goyal RK. Phyto-Pharmacology of Moringa Oleifera Lam: An overview. Nat Prod Rad 2007;6:34753. |
|9.||Khan M, Patil PA, Shobha JC. Influence of Bryophyllum pinnatum (Lam.) leaf extract on wound healing in albino rats. J Nat Rem 2004;4:41-6. |
|10.||Hukkeri VI, Nagathan CV, Karadi RV, Patil BS. Antipyretic and wound healing activities of Moringa oleifera Lam. in rats. Indian J Pharm Sci 2006;68:124-6. |
|11.||Satyavati GV, Gupta AK. Medicinal plants of India. Indian Council of Medical Research. 1987;2:272-8. |
|12.||Selvakumar D, Natarajan P. Hepato-Protective activity of Moringa oleifera Lam. leaves in carbon tetrachloride induced hepato-toxicity in albino rats. Pharmacogn Mag 2008;4:97-8. |
|13.||Laemmli UK. Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature 1970;227:680-5. |
|14.||Murata J, Satake M, Suzuki T. Studies on snake venom. XII. Distribution of proteinase activities among Japanese and Formosan snake venoms. J Biochem 1963;53:431-43. |
|15.||Kim SH, Choi NS, Lee WY. Fibrin zymography: A direct analysis of fibrinolytic enzymes on gels. Anal Biochem 1998;263:115-6. |
|16.||Condrea E, Yang CC, Rosenberg P. Anticoagulant activity and plasma phophatidylserine hydrolysis by snake venom phospholipase A2. Thromb Haemost 1983;49:151-7. |
|17.||Ouyang C, Teng CM. Fibrinogenolytic enzymes of Trimeresurus mucrosqua- matus Venom. Biochim Biophys Acta 1976;420:298-308. |
|18.||Joo HS, Park GC, Cho WR, Tak E, Paik SR, Chang CS. Purification and characterization of a prothrombin-activating protease from Nephila ciavata. Toxicon 2002;40:289-96. |
|19.||Rajesh R, Gowda CD, Nataraju A, Dhananjaya BL, Kemparaju K, Vishwanath BS. Procoagulant activity of Calotropis gigantea latex associated with fibrin (ogen) olytic activity. Toxicon 2005;46:84-92. |
|20.||Gene A, Roy G, Rojas JM, Gutierrez S, Cerdas L. Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom. Toxicon 1989;27:841-8. |
|21.||Komori Y, Sugihara H, Tu AT. Specificity of haemorrhagic proteinase from Crotalus atrox (Western diamond back rattle snake) venom. Biochim Biophys Acta 1985;829:127-30. |
|22.||Lijnen HR. Matrix metalloprotenases and their cellular fibrinolytic activity. Biochemistry (Mosc) 2002;67:92-8. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8]
|This article has been cited by|
||Antioxidative Effect and DNA Protecting Property ofMoringa oleiferaRoot Extracts
| ||A. Satish,P. Vanitha Reddy,Sudha Sairam,Faiyaz Ahmed,Asna Urooj |
| ||Journal of Herbs, Spices & Medicinal Plants. 2014; 20(3): 209 |
|[Pubmed] | [DOI]|
||antioxidative effect and dna protecting property of moringa oleifera root extracts
| ||satish, a. and reddy, p.v. and sairam, s. and ahmed, f. and urooj, a. |
| ||journal of herbs, spices and medicinal plants. 2014; 20(3): 209-220 |
||Protein-Rich Fraction of Cnidoscolus urens (L.) Arthur Leaves: Enzymatic Characterization and Procoagulant and Fibrinogenolytic Activities
| ||Yamara de Menezes,Juliana Félix-Silva,Arnóbio da Silva-Júnior,Ivanise Rebecchi,Adeliana de Oliveira,Adriana Uchoa,Matheus Fernandes-Pedrosa |
| ||Molecules. 2014; 19(3): 3552 |
|[Pubmed] | [DOI]|
||Evaluation of hemostatic activity of latex from three Euphorbiaceae species
| ||Shamkant B. Badgujar |
| ||Journal of Ethnopharmacology. 2014; 151(1): 733 |
|[Pubmed] | [DOI]|
||Caseinolytic and milk-clotting activities from Moringa oleifera flowers
| ||Emmanuel V. Pontual,Belany E.A. Carvalho,Ranilson S. Bezerra,Luana C.B.B. Coelho,Thiago H. Napoleão,Patrícia M.G. Paiva |
| ||Food Chemistry. 2012; 135(3): 1848 |
|[Pubmed] | [DOI]|